Drug profile · INN
fenfluramine hydrochloride
FINTEPLA
fenfluramine hydrochloride (FINTEPLA) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — fenfluramine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
fenfluramine hydrochloride (FINTEPLA) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2c (5-HT2c) receptor agonist
Primary target: 5-hydroxytryptamine receptor 1D
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fenfluramine hydrochloride?
fenfluramine hydrochloride (FINTEPLA) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fenfluramine hydrochloride?
FINTEPLA is a marketed brand name for fenfluramine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fenfluramine hydrochloride?
fenfluramine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.